|
Schlusskurs
Nasdaq
|
||
| - USD | - |
|
| 26.06.23 | Sobi schließt Übernahme von CTI BioPharma für 1,7 Mrd. Dollar ab | MT |
| 26.06.23 | Swedish Orphan Biovitrum schließt Übernahmeangebot für CTI BioPharma ab | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.56% | -4.71% | -5.05% | +8.95% | -0.67% | -2.45% | +9.18% | -31.21% | +193.19% | 45.48 Mrd. | |
| +0.66% | -2.34% | +0.69% | +33.30% | +157.51% | +340.62% | +530.14% | +594.11% | - | 43.68 Mrd. | |
| +1.49% | -0.78% | +12.26% | +46.41% | +17.86% | +41.90% | +24.75% | +3.15% | +241.04% | 43.09 Mrd. | |
| +2.11% | -1.24% | +1.83% | +33.78% | +16.46% | +9.09% | +78.25% | -4.08% | +953.69% | 39.4 Mrd. | |
| +0.34% | -4.03% | -11.04% | +3.35% | +3.72% | +9.34% | +38.90% | -17.31% | +135.16% | 31.91 Mrd. | |
| +0.53% | -2.08% | +6.61% | +21.49% | - | - | - | - | - | 17.31 Mrd. | |
| +1.34% | +0.70% | +2.92% | +27.40% | +6.01% | +21.35% | +112.62% | +228.83% | +1’875.48% | 16.4 Mrd. | |
| +2.07% | +0.78% | +2.44% | +12.61% | +15.64% | +13.07% | +30.91% | -41.52% | +92.79% | 14.24 Mrd. | |
| -1.85% | -5.33% | -2.48% | +45.65% | +36.91% | +78.63% | +31.45% | -37.39% | +239.01% | 13.28 Mrd. | |
| -0.22% | +2.47% | +3.54% | +15.56% | -7.29% | -3.47% | -35.47% | -36.33% | +121.32% | 13.06 Mrd. | |
| +0.21% | -0.22% | -0.18% | +33.83% | +22.89% | +40.99% | -2.39% | -43.31% | +170.14% | 11.31 Mrd. | |
| +5.42% | -3.73% | +19.40% | +30.09% | +5.35% | -27.98% | - | - | - | 10.65 Mrd. | |
| -1.63% | +1.74% | -2.97% | +17.17% | -17.23% | +40.95% | +504.67% | +205.21% | +1’263.20% | 10.25 Mrd. | |
| +5.88% | +3.37% | -13.17% | +90.57% | +50.02% | +26.37% | +56.80% | -53.16% | - | 10.13 Mrd. | |
| -0.27% | +1.41% | -4.72% | +34.61% | +69.20% | +151.07% | +721.00% | +227.96% | +1’028.09% | 9.59 Mrd. | |
| -0.29% | -2.35% | -2.35% | +32.97% | +47.32% | +143.95% | +491.49% | +81.46% | - | 9.56 Mrd. | |
| -1.20% | -6.04% | -9.89% | +24.00% | +12.15% | +776.67% | +1’582.19% | +8.61% | - | 9.34 Mrd. | |
| -3.35% | -5.13% | +26.15% | +178.81% | +164.90% | +92.96% | +69.24% | +0.61% | +1’200.40% | 9.02 Mrd. | |
| -5.11% | -11.45% | -10.13% | -29.80% | -34.98% | -18.56% | +17.87% | +42.06% | +68.88% | 9.01 Mrd. | |
| Durchschnitt | +0.01% | -1.96% | +0.73% | +34.78% | +31.43% | +96.36% | +250.68% | +66.33% | +583.26% | 19.3 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.51% | -2.42% | +0.77% | +30.33% | +34.78% | +86.91% | +189.23% | +90.47% | +503.97% |
- Börse
- Aktien
- A2DJWX Aktie
- Aktie
- Sektor Cell Therapeutics Inc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
